Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
28.97M
Enterprise Value
32.57M
Income
-4.47M
Sales
3.91M
Book/sh
0.90
Cash/sh
0.01
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
221
IPO
Apr 17, 2002
P/E
-
Forward P/E
-
PEG
-
P/S
7.41
P/B
0.75
P/C
93.47
P/FCF
-
EV/EBITDA
-
EV/Sales
8.33
Quick Ratio
0.08
Current Ratio
0.26
Debt/Eq
0.11
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-0.42
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
73.01% 53.14%
Sales past 3/5Y
-20.03% -17.53%
EPS Y/Y TTM
71.83%
Sales Y/Y TTM
-10.97%
EPS Q/Q
77.78%
Sales Q/Q
-7.55%
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
6.23%
Insider Trans
0.00%
Inst Own
0.47%
Inst Trans
479.65%
ROA
-15.21%
ROE
-20.81%
ROIC
-12.28%
Gross Margin
-47.35%
Oper. Margin
-111.84%
Profit Margin
-114.33%
SMA20
-7.86%
SMA50
-16.90%
SMA200
-21.04%
Trades
Shs Outstand
40.52M
Shs Float
40.34M
52W High
19.19 -96.49%
52W Low
0.38 76.38%
Volatility
9.33% 18.60%
ATR (14)
0.12
RSI (14)
43.11
Beta
0.96
Rel Volume
0.05
Avg Volume
2.36M
Volume
121,276
Perf Week
-7.49%
Perf Month
-6.47%
Perf Quarter
-55.70%
Perf Half Y
14.12%
Perf YTD
-44.35%
Perf Year
-59.92%
Perf 3Y
-88.03%
Perf 5Y
-99.77%
Perf 10Y
-99.37%
Recom
-
Target Price
-
Prev Close
0.70
Price
0.67
Change %
-3.39%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.
PresidentMs. Zhilin Li
BOD Secretary & IR ManagerMs. Huang Na C.F.A.